Lonza Tweet15 Jun 2018 18:28
Lonza, in collaboration with @KirkstallLtd Ltd, is hosting a webinar on the development of more physiologically relevant 3D lung-immune cell models for enhanced disease modeling. Watch the live webinar on Monday, 25 June: goo.gl/7nu9GT #3dcellculture #diseasemodeling. Let’s not forget Lonza are a $20bn market cap company and BTH currently own 43% of Kirkstall